Cellular MYCro economics: Balancing MYC function with MYC expression

Cold Spring Harbor Perspectives in Medicine

Volumn 3, Issue 11, 2013, Pages

  Levens, David ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANAPHASE PROMOTING COMPLEX; DNA BINDING PROTEIN; DNA HELICASE; DNA TOPOISOMERASE; DNA Z; HISTONE ACETYLTRANSFERASE; MESSENGER RNA; MYC PROTEIN; NUCLEOLIN; OLIGONUCLEOTIDE; TRISTETRAPROLIN;

ARTICLE; CHROMATIN ASSEMBLY AND DISASSEMBLY; DNA BINDING; DNA CONFORMATION; DNA TRANSCRIPTION; DOWN REGULATION; E BOX ELEMENT; GENE ACTIVITY; GENE AMPLIFICATION; GENE EXPRESSION; HETEROCHROMATIN; HUMAN; NONHUMAN; NUCLEOSOME; PROMOTER REGION; PROTEIN DEGRADATION; PROTEIN EXPRESSION; RNA SYNTHESIS; RNA TRANSCRIPTION; SINGLE NUCLEOTIDE POLYMORPHISM; TRANSCRIPTION INITIATION SITE; TRANSCRIPTION REGULATION; UPREGULATION;

DNA; GENE AMPLIFICATION; GENES, MYC; HUMANS; PROMOTER REGIONS, GENETIC; PROTO-ONCOGENE PROTEINS C-MYC;

EID: 84887191036     PISSN: None     EISSN: 21571422     Source Type: Journal    
DOI: 10.1101/cshperspect.a014233     Document Type: Article

References (92)

1. Abrams H. D, Rohrschneider LR, Eisenman RN. 1982. Nuclear location of the putative transforming protein of avian myelocytomatosis virus. Cell 29: 427-439.
2. Adelman K., Lis JT. 2012. Promoter-proximal pausing of RNA polymerase II: Emerging roles in metazoans. Nat Rev Genet 13: 720-731.
3. Agrawal P., Yu K, Salomon AR, Sedivy JM. 2010. Proteomic profiling of Myc-associated proteins. Cell Cycle 9: 4908-4921.
4. Alitalo K., SchwabM, Lin CC, Varmus HE, Bishop JM. 1983. Homogeneously staining chromosomal regions contain amplified copies of an abundantly expressed cellular oncogene (c-myc) in malignant neuroendocrine cells froma human colon carcinoma. Proc Natl Acad Sci 80: 1707-1711.
5. Alon U. 2007. An introduction to systems biology: Design principles of biological circuits. Chapman & Hall/CRC, Boca Raton, FL.
6. Amati B., Frank SR, Donjerkovic D, Taubert S. 2001. Function of the c-Myc oncoprotein in chromatin remodeling and transcription. Biochim Biophys Acta 1471: M135-M145.
7. Benjamin L. R, Chung HJ, Sanford S, Kouzine F, Liu J, Levens D. 2008. Hierarchical mechanisms build the DNA-binding specificity of FUSE binding protein. Proc Natl Acad Sci 105: 18296-18301.
8. Blackwood E. M, Eisenman RN. 1991. Max: A helix-loophelix zipper protein that forms a sequence-specific DNA-binding complex with Myc. Science 251: 1211-1217.
9. Boxer L. M, Dang CV. 2001. Translocations involving c-myc and c-myc function. Oncogene 20: 5595-5610.
10. Braddock D. T, Baber JL, Levens D, Clore GM. 2002. Molecular basis of sequence-specific single-stranded DNA recognition by KH domains: Solution structure of a complex between hnRNP K KH3 and single-stranded DNA. EMBO J 21: 3476-3485.
11. Brooks T. A, Hurley LH. 2009. The role of supercoiling in transcriptional control of MYC and its importance in molecular therapeutics. Nat Rev Cancer 9: 849-861.
12. Cowling V. H, ColeMD. 2006. Mechanism of transcriptional activation by the Myc oncoproteins. Semin Cancer Biol 16: 242-252.
13. Cowling V. H, Cole MD. 2007. The Myc transactivation domain promotes global phosphorylation of the RNA polymerase II carboxy-terminal domain independently of direct DNA binding. Mol Cell Biol 27: 2059-2073.
14. Crichlow G. V, Zhou H, Hsiao HH, Frederick KB, Debrosse M, Yang Y, Folta-Stogniew EJ, Chung HJ, Fan C, De la Cruz E. M, et al. 2008. Dimerization of FIR upon FUSE DNA binding suggests a mechanism of c-myc inhibition. EMBO J 27: 277-289.
15. Dang C.V. 2010. Enigmatic MYC conducts an unfolding systems biology symphony. Genes Cancer 1: 526-531.
16. Dang C.V. 2012. MYCon the path to cancer. Cell 149: 22-35.
17. Davey C. A, Sargent DF, Luger K, Maeder AW, Richmond TJ. 2002. Solvent mediated interactions in the structure of the nucleosome core particle at 1.9 a resolution. J Mol Biol 319: 1097-1113.
18. de la Cova C, Abril M, Bellosta P, Gallant P, Johnston LA. 2004. Drosophila Myc regulates organ size by inducing cell competition. Cell 117: 107-116.
19. Eilers M., Eisenman RN. 2008. Myc's broad reach. Genes Dev 22: 2755-2766.
20. Eilers M., Picard D, Yamamoto KR, Bishop JM. 1989. Chimaeras of myc oncoprotein and steroid receptors cause hormone-dependent transformation of cells. Nature 340: 66-68.
21. Eisenman R. 2013. An overviewofMYC and its interactome. Cold Spring Harb Perspect Med doi: 10.1101/cshperspect. a014357.
22. Farrell AS, Sears RC. 2013. MYC degradation. Cold Spring Harb Perspect Med doi: 10.1101/cshperspect.a014365.
23. Gonzalez V., Guo K, Hurley L, Sun D. 2009. Identification and characterization of nucleolin as a c-myc G-quadruplex-binding protein. J Biol Chem 284: 23622-23635.
24. Guney I., Wu S, Sedivy JM. 2006. Reduced c-Myc signaling triggers telomere-independent senescence by regulating Bmi-1 and p16INK4a. Proc Natl Acad Sci 103: 3645-3650.
25. Hay N., Bishop JM, Levens D. 1987. Regulatory elements that modulate expression of human C-Myc. Genes Dev 1: 659-671.
26. He T. C, Sparks AB, Rago C, Hermeking H, Zawel L, da Costa LT, Morin PJ, Vogelstein B, Kinzler KW. 1998. Identification of c-MYC as a target of the APC pathway. Science 281: 1509-1512.
27. Iritani B. M, Eisenman RN. 1999. c-Myc enhances protein synthesis and cell size during B lymphocyte development. Proc Natl Acad Sci 96: 13180-13185.
28. Janz S. 2006. Myc translocations in B cell and plasma cell neoplasms. DNA Repair (Amst) 5: 1213-1224.
29. Ji H., Wu G, Zhan X, Nolan A, Koh C, De Marzo A, Doan HM, Fan J, Cheadle C, Fallahi M, et al. 2011. Cell-type independent MYC target genes reveal a primordial signature involved in biomass accumulation. PLoS ONE 6: e26057.
30. Johnston LA. 2013. Socializing with Myc: Cell competition in develoment and as a model for premalignant cancer. Cold Spring Harb Perspect Med doi: 10.1101/cshperspect. a014274.
31. Johnston L. A, Prober DA, Edgar BA, Eisenman RN, Gallant P. 1999. Drosophila myc regulates cellular growth during development. Cell 98: 779-790.
32. Kaur M., Cole MD. 2013. MYC acts via the PTEN tumor suppressor to elicit autoregulation and genome-wide gene repression by activation of the Ezh2 methyltransferase. Cancer Res 73: 695-705.
33. Kim J., Woo AJ, Chu J, Snow JW, Fujiwara Y, Kim CG, Cantor AB, Orkin SH. 2010. A Myc network accounts for similarities between embryonic stem and cancer cell transcription programs. Cell 143: 313-324.
34. Kouzine F., LevensD. 2007. Supercoil-drivenDNA structures regulate genetic transactions. Front Biosci 12: 4409-4423.
35. Kouzine F., Liu JH, Sanford S, Chung HJ, Levens D. 2004. The dynamic response of upstream DNA to transcription-generated torsional stress. Nat Struct Mol Biol 11: 1092-1100.
36. Kouzine F., Sanford S, Elisha-Feil Z, Levens D. 2008. The functional response of upstream DNA to dynamic supercoiling in vivo. Nat Struct Mol Biol 15: 146-154.
37. Kouzine F., Wojtowicz D, Yamane A, ReschW, Kieffer-Kwon K-R, Bandle R, Nelson S, Nakahashi H, Awasthi P, Feigenbaum L, et al. 2013. Global regulation of promoter melting in naive lymphocytes. Cell 153: 988-999.
38. Kovalchuk A. L, Ansarah-Sobrinho C, Hakim O, Resch W, Tolarova H., Dubois W, Yamane A, Takizawa M, Klein I, Hager G. L, et al. 2012. Mouse model of endemic Burkitt translocations reveals the long-range boundaries of Igmediated oncogene deregulation. Proc Natl Acad Sci 109: 10972-10977.
39. Krumm A., Hickey LB, Groudine M. 1995. Promoterproximal pausing of RNA polymerase II defines a general rate-limiting step after transcription initiation. Genes Dev 9: 559-572.
40. Lavelle C. 2009. Forces and torques in the nucleus: Chromatin under mechanical constraints. Biochem Cell Biol 87: 307-322.
41. Lebel R., McDuff FO, Lavigne P, Grandbois M. 2007. Direct visualization of the binding of c-Myc/Max heterodimeric b-HLH-LZ to E-box sequences on the hTERT promoter. Biochemistry 46: 10279-10286.
42. Levens D. 2010. You don't muck with Myc. Genes Cancer 1: 547-554.
43. Levens D., Benham CJ. 2011. DNA stress and strain, in silico, in vitro and in vivo. Phys Biol 8: 035011.
44. Levine M. 2011. Paused RNA polymerase II as a developmental checkpoint. Cell 145: 502-511.
45. Lin C. Y, Loven J, Rahl PB, Paranal RM, Burge CB, Bradner JE, Lee T. I, Young RA. 2012. Transcriptional amplification in tumor cells with elevated c-Myc. Cell 151: 56-67.
46. Littlewood T. D, Hancock DC, Danielian PS, Parker MG, Evan G.I. 1995. A modified oestrogen receptor ligandbinding domain as an improved switch for the regulation of heterologous proteins. Nucleic Acids Res 23: 1686-1690.
47. Liu J., Levens D. 2006. Making myc. Curr Top Microbiol Immunol 302: 1-32.
48. Liu L. F, Wang JC. 1987. Supercoiling of the DNA-template during transcription. Proc Natl Acad Sci 84: 7024-7027.
49. Liu J. H, Akoulitchev S, Weber A, Ge H, Chuikov S, LibuttiD, Wang X. W, Conaway JW, Harris CC, Conaway RC, et al. 2001. Defective interplay of activators and repressorswith TFIIH in xeroderma pigmentosum. Cell 104: 353-363.
50. Liu J., Kouzine F, Nie Z, Chung HJ, Elisha-Feil Z, Weber A, Zhao K., Levens D. 2006. The FUSE/FBP/FIR/TFIIH system is a molecular machine programming a pulse of c-myc expression. EMBO J 25: 2119-2130.
51. Love C., Sun Z, Jima D, Li G, Zhang J, Miles R, Richards KL, Dunphy C. H, Choi WW, Srivastava G, et al. 2012. The genetic landscape of mutations in Burkitt lymphoma. Nat Genet 44: 1321-1325.
52. Loven J., OrlandoDA, Sigova AA, Lin CY, Rahl PB, Burge CB, Levens D. L, Lee TI, Young RA. 2012. Revisiting global gene expression analysis. Cell 151: 476-482.
53. Luger K., Mader AW, Richmond RK, Sargent DF, Richmond TJ. 1997. Crystal structure of the nucleosome core particle at 2.8 A resolution. Nature 389: 251-260.
54. Luo Z., Lin C, Shilatifard A. 2012. The super elongation complex (SEC) family in transcriptional control. Nat Rev Mol Cell Biol 13: 543-547.
55. Margolin A. A, Palomero T, Sumazin P, Califano A, Ferrando AA, Stolovitzky G. 2009. ChIP-on-chip significance analysis reveals large-scale binding and regulation by human transcription factor oncogenes. Proc Natl Acad Sci 106: 244-249.
56. Michelotti G. A, Michelotti EF, Pullner A, Duncan RC, Eick D, Levens D. 1996. Multiple single-stranded cis elements are associated with activated chromatin of the human c-myc gene in vivo. Mol Cell Biol 16: 2656-2669.
57. Mitchell N. C, Johanson TM, Cranna NJ, Er AL, Richardson HE, Hannan RD, Quinn LM. 2010. Hfp inhibits DrosophilaMyc transcription and cell growth in a TFIIH/Haydependent manner. Development 137: 2875-2884.
58. Moelling K., Owada MK, Greiser-Wilke I, Bunte T, Donner P. 1982. Biochemical characterization of transformationspecific proteins of acute avian leukemia and sarcoma viruses. J Cell Biochem 20: 63-69.
59. Moreno E., Basler K. 2004. dMyc transforms cells into supercompetitors. Cell 117: 117-129.
60. Mulholland N., Xu Y, Sugiyama H, Zhao K. 2012. SWI/SNFmediated chromatin remodeling induces Z-DNA formation on a nucleosome. Cell Biosci 2: 3.
61. Murphy D. J, Junttila MR, Pouyet L, Karnezis A, Shchors K, Bui D. A, Brown-Swigart L, Johnson L, Evan GI. 2008. Distinct thresholds govern Myc's biological output in vivo. Cancer Cell 14: 447-457.
62. Nagl N. G Jr, Wang X, Patsialou A, Van Scoy M, Moran E. 2007. Distinct mammalian SWI/SNF chromatin remodeling complexes with opposing roles in cell-cycle control. EMBO J 26: 752-763.
63. Nair S. K, Burley SK. 2003. X-ray structures ofMyc-Max and Mad-Max recognizing DNA. Molecular bases of regulation by proto-oncogenic transcription factors. Cell 112: 193-205.
64. Ni M., Chen Y, Fei T, Li D, Lim E, Liu XS, Brown M. 2013. Amplitude modulation of androgen signaling by c-MYC. Genes Dev 27: 734-748.
65. Nie Z., Hu G, Wei G, Cui K, Yamane A, Resch W, Wang R, Green D. R, Tessarollo L, Casellas R, et al. 2012. c-Myc is a universal amplifier of expressed genes in lymphocytes and embryonic stem cells. Cell 151: 68-79.
66. O'Connell BC, Cheung AF, Simkevich CP, Tam W, Ren X, Mateyak M. K, Sedivy JM. 2003. A large scale genetic analysis of c-Myc-regulated gene expression patterns. J Biol Chem 278: 12563-12573.
67. Park S., Chung S, KimKM, Jung KC, Park C, Hahm ER, Yang CH. 2004. Determination of binding constant of transcription factor myc-max/max-max and E-box DNA: The effect of inhibitors on the binding. Biochim Biophys Acta 1670: 217-228.
68. Peter M., Rosty C, Couturier J, Radvanyi F, Teshima H, Sastre-Garau X. 2006. MYC activation associated with the integration of HPV DNA at the MYC locus in genital tumors. Oncogene 25: 5985-5993.
69. Pomerantz M. M, Ahmadiyeh N, Jia L, Herman P, Verzi MP, Doddapaneni H., Beckwith CA, Chan JA, Hills A, Davis M, et al. 2009. The 8q24 cancer risk variant rs6983267 shows long-range interaction with MYC in colorectal cancer. Nat Genet 41: 882-884.
70. Rahl PB, Young RA. 2013. Myc and transcription elongation. Cold Spring Harb Perspect Med doi: 10.1101/cshperspect. a014340.
71. Rahl P. B, Lin CY, Seila AC, Flynn RA, McCuine S, Burge CB, Sharp P. A, Young RA. 2010. c-Myc regulates transcriptional pause release. Cell 141: 432-445.
72. Schuhmacher M., Staege MS, Pajic A, Polack A, Weidle UH, Bornkamm G. W, Eick D, Kohlhuber F. 1999. Control of cell growth by c-Myc in the absence of cell division. Curr Biol 9: 1255-1258.
73. Seila A. C, Core LJ, Lis JT, Sharp PA. 2009. Divergent transcription: A new feature of active promoters. Cell Cycle 8: 2557-2564.
74. Shachaf C. M, Gentles AJ, Elchuri S, Sahoo D, Soen Y, Sharpe O, Perez OD, Chang M, Mitchel D, Robinson WH, et al. 2008. Genomic and proteomic analysis reveals a threshold level of MYC required for tumor maintenance. Cancer Res 68: 5132-5142.
75. Shaffer A. L, Wright G, Yang L, Powell J, Ngo V, Lamy L, Lam LT, Davis RE, Staudt LM. 2006. A library of gene expression signatures to illuminate normal and pathological lymphoid biology. Immunol Rev 210: 67-85.
76. Shrivastava A., Yu J, Artandi S, Calame K. 1996. YY1 and c-Myc associate in vivo in a manner that depends on c-Myc levels. Proc Natl Acad Sci 93: 10638-10641.
77. Sinden R.R. 1994. DNA structure and function. Academic Press, San Diego.
78. Sotelo J., Esposito D, Duhagon MA, Banfield K, Mehalko J, Liao H., Stephens RM, Harris TJ, Munroe DJ, Wu X. 2010. Long-range enhancers on 8q24 regulate c-Myc. Proc Natl Acad Sci 107: 3001-3005.
79. Spencer C. A, Groudine M. 1990. Transcription elongation and eukaryotic gene regulation. Oncogene 5: 777-785.
80. Sur I. K, HallikasO, Vaharautio A, Yan J, Turunen M, Enge M, Taipale M., Karhu A, Aaltonen LA, Taipale J. 2012. Mice lacking a Myc enhancer that includes human SNP rs6983267 are resistant to intestinal tumors. Science 338: 1360-1363.
81. Trumpp A., Refaeli Y, Oskarsson T, Gasser S, Murphy M, Martin G. R, Bishop JM. 2001. c-Myc regulates mammalian body size by controlling cell number but not cell size. Nature 414: 768-773.
82. Tuupanen S., Turunen M, Lehtonen R, Hallikas O, Vanharanta S, Kivioja T, Bjorklund M, WeiG, Yan J, Niittymaki I, et al. 2009. The common colorectal cancer predisposition SNP rs6983267 at chromosome 8q24 confers potential to enhanced Wnt signaling. Nat Genet 41: 885-890.
83. Valverde R., Edwards L, Regan L. 2008. Structure and function of KH domains. FEBS J 275: 2712-2726.
84. Vennstrom B., Sheiness D, Zabielski J, Bishop JM. 1982. Isolation and characterization of c-myc, a cellular homolog of the oncogene (v-myc) of avian myelocytomatosis virus strain 29. J Virol 42: 773-779.
85. Walz S., Eilers M. 2013. Unlocking the mysterious mechanisms of Myc. Nat Med 19: 26-27.
86. Wasylishen A. R, Penn LZ. 2010. Myc: The beauty and the beast. Genes Cancer 1: 532-541.
87. Wierstra I., Alves J. 2008. The c-myc promoter: Still MysterY and challenge. Adv Cancer Res 99: 113-333.
88. Wolfl S., Wittig B, Rich A. 1995. Identification of transcriptionally induced Z-DNA segments in the human c-myc gene. Biochim Biophys Acta 1264: 294-302.
89. Wolfl S., Wittig B, Dorbic T, Rich A. 1997. Identification of processes that influence negative supercoiling in the human c-myc gene. Biochim Biophys Acta 1352: 213-221.
90. Yap C. S, Peterson AL, Castellani G, Sedivy JM, Neretti N. 2011. Kinetic profiling of the c-Myc transcriptome and bioinformatic analysis of repressed gene promoters. Cell Cycle 10: 2184-2196.
91. Yochum G. S, Cleland R, Goodman RH. 2008. A genomewide screen for β-catenin binding sites identifies a downstream enhancer element that controls c-Myc gene expression. Mol Cell Biol 28: 7368-7379.
92. Yochum G. S, Sherrick CM, Macpartlin M, Goodman RH. 2010. A β-catenin/TCF-coordinated chromatin loop at MYC integrates 5′ and 3′ Wnt responsive enhancers. Proc Natl Acad Sci 107: 145-150.